-+ 0.00%
-+ 0.00%
-+ 0.00%

Livzon Wins China Approval for Tiange Dingxuan Clinical Trials

PUBT·10/27/2026 08:51:38
Listen to the news
Livzon Wins China Approval for Tiange Dingxuan Clinical Trials
  • Livzon Pharmaceutical subsidiary Sichuan Guangda secured Chinese regulatory clearance for clinical trials of Tiange Dingxuan Granules for vestibular migraine.
  • Trials are subject to further refinement of the clinical protocol.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Livzon Pharmaceutical Group Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261027-12384146), on October 27, 2026, and is solely responsible for the information contained therein.